BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mhanna A, Franklin WH, Mancini AJ. Hepatic Infantile Hemangiomas Treated with Oral Propranolol-A Case Series: Hepatic Infantile Hemangiomas. Pediatric Dermatology 2011;28:39-45. [DOI: 10.1111/j.1525-1470.2010.01355.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Abarzúa-araya Á, Navarrete-dechent CP, Heusser F, Retamal J, Zegpi-trueba MS. Atenolol versus propranolol for the treatment of infantile hemangiomas: A randomized controlled study. Journal of the American Academy of Dermatology 2014;70:1045-9. [DOI: 10.1016/j.jaad.2014.01.905] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 7.3] [Reference Citation Analysis]
2 North K, Campbell H, Macdougall J, Chamberlain G, Wood K. Case 2: A Newborn With a Liver Mass, Coagulopathy, and High-Output Cardiac Failure. Neoreviews 2020;21:e407-10. [PMID: 32482703 DOI: 10.1542/neo.21-6-e407] [Reference Citation Analysis]
3 Sethuraman G, Yenamandra VK, Gupta V. Management of infantile hemangiomas: current trends. J Cutan Aesthet Surg 2014;7:75-85. [PMID: 25136206 DOI: 10.4103/0974-2077.138324] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
4 Baena-gómez M, Priego Ruiz M, González E, Peña Rosa M, Muñoz Sánchez R. Hepatic hemangiomas: Spectacular response to treatment with propranolol. Anales de Pediatría (English Edition) 2015;83:435-7. [DOI: 10.1016/j.anpede.2015.10.016] [Reference Citation Analysis]
5 Mcguire A, Fernandez-pineda I, Fishman SJ, Dickie BH. Pediatric hepatic vascular tumors. Seminars in Pediatric Surgery 2020;29:150970. [DOI: 10.1016/j.sempedsurg.2020.150970] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Püttgen KB. Diagnosis and management of infantile hemangiomas. Pediatr Clin North Am 2014;61:383-402. [PMID: 24636652 DOI: 10.1016/j.pcl.2013.11.010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
7 Campbell V, Beckett R, Abid N, Hoey S. Resolution of Consumptive Hypothyroidism Secondary to Infantile Hepatic Hemangiomatosis with a Combination of Propranolol and Levothyroxine. J Clin Res Pediatr Endocrinol 2018;10:294-8. [PMID: 29537380 DOI: 10.4274/jcrpe.4865] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
8 Rubinstein JC, Christison-lagay ER. Successful treatment of visceral infantile hemangioma of the omentum and mesentery with propranolol. Journal of Pediatric Surgery Case Reports 2014;2:302-4. [DOI: 10.1016/j.epsc.2014.06.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, Chun RH, Garzon MC, Holland KE, Liberman L. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131:128-140. [PMID: 23266923 DOI: 10.1542/peds.2012-1691] [Cited by in Crossref: 304] [Cited by in F6Publishing: 219] [Article Influence: 30.4] [Reference Citation Analysis]
10 Frommelt P, Juern A, Siegel D, Holland K, Seefeldt M, Yu J, Uhing M, Wade K, Drolet B. Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma. Pediatr Dermatol 2016;33:405-14. [DOI: 10.1111/pde.12869] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 6.7] [Reference Citation Analysis]
11 Bosemani T, Puttgen KB, Huisman TA, Tekes A. Multifocal infantile hepatic hemangiomas--imaging strategy and response to treatment after propranolol and steroids including review of the literature. Eur J Pediatr. 2012;171:1023-1028. [PMID: 22234480 DOI: 10.1007/s00431-011-1671-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
12 Hogeling M. Propranolol for Infantile Hemangiomas: A Review. Curr Derm Rep 2012;1:179-85. [DOI: 10.1007/s13671-012-0026-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Maaloul I, Aloulou H, Hentati Y, Kamoun T, Mnif Z, Hachicha M. Infantile hepatic hemangioendothelioma successfully treated by low dose of propranolol. Presse Med 2017;46:454-6. [PMID: 28318668 DOI: 10.1016/j.lpm.2017.01.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Ferrandiz L, Toledo-Pastrana T, Moreno-Ramirez D, Bardallo-Cruzado L, Perez-Bertolez S, Luna-Lagares S, Rios-Martin JJ. Diffuse neonatal hemangiomatosis with partial response to propranolol. Int J Dermatol. 2014;53:e247-e250. [PMID: 23834677 DOI: 10.1111/ijd.12155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
15 Fernández Ibieta M, Méndez Aguirre NA, Girón Vallejo O, Ruiz Jiménez JI. [Rapid response of a multifocal liver hemangioma to propranolol treatment]. An Pediatr (Barc) 2013;79:122-3. [PMID: 23402776 DOI: 10.1016/j.anpedi.2012.10.013] [Reference Citation Analysis]
16 Foley LS, Kulungowski AM. Vascular Anomalies in Pediatrics. Advances in Pediatrics 2015;62:227-55. [DOI: 10.1016/j.yapd.2015.04.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
17 Lee KC, Bercovitch L. Update on infantile hemangiomas. Semin Perinatol. 2013;37:49-58. [PMID: 23419763 DOI: 10.1053/j.semperi.2012.11.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
18 Thompson PA, Chintagumpala M. Renal and hepatic tumors in the neonatal period. Semin Fetal Neonatal Med. 2012;17:216-221. [PMID: 22595862 DOI: 10.1016/j.siny.2012.04.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
19 Kwon EK, Seefeldt M, Drolet BA. Infantile hemangiomas: an update. Am J Clin Dermatol 2013;14:111-23. [PMID: 23338947 DOI: 10.1007/s40257-013-0008-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
20 Hsi Dickie B, Fishman SJ, Azizkhan RG. Hepatic vascular tumors. Semin Pediatr Surg. 2014;23:168-172. [PMID: 25241093 DOI: 10.1053/j.sempedsurg.2014.06.018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
21 Baena-Gómez MA, Priego Ruiz MP, Mateos González E, Peña Rosa MJ, Muñoz Sánchez R. [Hepatic hemangiomas: Spectacular response to treatment with propranolol]. An Pediatr (Barc) 2015;83:435-7. [PMID: 26122492 DOI: 10.1016/j.anpedi.2015.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Yang K, Peng S, Chen L, Chen S, Ji Y. Efficacy of propranolol treatment in infantile hepatic haemangioma. J Paediatr Child Health 2019;55:1194-200. [DOI: 10.1111/jpc.14375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Zegpi-Trueba MS, Abarzúa-Araya A, Silva-Valenzuela S, Navarrete-Dechent C, Uribe-González P, Nicklas-Díaz C. Oral propranolol for treating infantile hemangiomas: a case series of 57 patients. Actas Dermosifiliogr 2012;103:708-17. [PMID: 22853960 DOI: 10.1016/j.ad.2012.03.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
24 Georgountzou A, Karavitakis E, Klimentopoulou A, Xaidara A, Kakourou T. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience. Acta Paediatr 2012;101:e469-74. [PMID: 22804809 DOI: 10.1111/j.1651-2227.2012.02783.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
25 Zhang XT, Ren WD, Song G, Xiao YJ, Sun FF, Wang N. Infantile hepatic hemangiomas associated with high-output cardiac failure and pulmonary hypertension. BMC Cardiovasc Disord 2019;19:216. [PMID: 31601179 DOI: 10.1186/s12872-019-1200-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]